PrO2+ is on the App Store. Download the companion app today for iPhone or Android to pair with your device and train anywhere.

A Comprehensive Examination of Inspiratory Muscle Performance from the Intensive Care Unit to Hospital Discharge in Patients with COVID-19
Back to studies

A Comprehensive Examination of Inspiratory Muscle Performance from the Intensive Care Unit to Hospital Discharge in Patients with COVID-19

Background: The two most common symptoms associated with COVID-19 are dyspnea and fatigue. One possible cause of such symptoms may be inspiratory muscle weakness.

Objectives: The purpose of this study was to examine inspiratory muscle performance (IMP) from intensive care unit discharge (ICUD) to hospital discharge (HD) in patients with COVID-19

Results: 30 patients (19 men, 11 women) with COVID-19 were included. The mean§SD age, BMI, and length
of ICU and hospital stay was 71§11 yrs, 27.9 § 6.3 kg/m, 9 § 6 days, and 26§16 days, respectively. The
mean§SD MIP, SMIP, ID, and FIT of the entire cohort at ICUD vs HD were 36§21 vs 40§20 cm H2O, 231§
157 vs 297§182 PTU, 8.8 § 4.2 vs 9.5 § 4.6 s, and 9.0 § 9.4 vs 13.1 § 12.3, respectively, with only SMIP and
FIT significantly greater at HD (p=.006 and 0.03, respectively). SMIP at HD was significantly related to resting
dyspnea at HD (r=-0.40; p=.02). The SMIP and FIT of men were found to increase significantly from ICUD to
HD, but no measure of IMP in the women increased significantly from ICUD to HD. At least one COVID-19-
related symptom was present 1 month after HD with the most persistent symptoms being fatigue, cough,
and dyspnea in 47%, 40%, and 37% of the patients, respectively.

Conclusions: A significant reduction in IMP exists in patients with COVID-19 at both ICUD and HD and no
measure of IMP in women was observed to increase significantly from ICUD to HD. Impaired inspiratory mus-
cle endurance rather than strength was associated with greater dyspnea at HD.

Read the full study